CymitQuimica logo

6-Bromocoumarin

CAS:

Ref. 3D-FB66420

1g
159.00€
2g
227.00€
5g
384.00€
10g
570.00€
25g
1,062.00€
6-Bromocoumarin
Biosynth

    Product Information

    Name:6-Bromocoumarin
    Brand:Biosynth
    Description:6-Bromocoumarin is a synthetic heterocycle that has been shown to be effective in the treatment of cervical cancer. It inhibits cholinesterase enzymes and causes cross-coupling reactions, which leads to DNA damage. 6-Bromocoumarin also displays anti-inflammatory properties and has been shown to inhibit phosphatases, as well as progesterone receptor in human lung cells. In addition, it displays fluorescence properties and has been shown to segregate into two phases when mixed with malonic acid. The mechanism of action involves the following steps: 1) 6-bromocoumarin reacts with the enzyme cholinesterase; 2) this reaction releases acetylcholine from the enzyme; 3) acetylcholine binds to muscarinic receptors on cells, leading to an increase in intracellular calcium levels; 4) increased intracellular calcium levels activate phosphatases, which are proteins that break down proteins
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:225.04 g/mol
    Formula:C9H5BrO2
    Purity:Min. 95%
    Color/Form:Powder

    Technical inquiry about: 6-Bromocoumarin

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.